ebymect
astrazeneca ab - dapagliflozin propanediol monohydrate, metformin hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes - type 2 diabetes mellitusfor the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise.as monotherapy when metformin is considered inappropriate due to intolerance.in addition to other medicinal products for the treatment of type 2 diabetes.for study results with respect to combination of therapies, effects on glycaemic control and cardiovascular events, and the populations studied, see sections 4.4, 4.5 and 5.1.type 1 diabetes mellitusedistride is indicated in adults for the treatment of insufficiently controlled type 1 diabetes mellitus as an adjunct to insulin in patients with bmi ≥ 27 kg/m2, when insulin alone does not provide adequate glycaemic control despite optimal insulin therapy.
qtern 5 mg10 mg film-coated tablets
astrazeneca sdn. bhd. - saxagliptin hydrochloride; dapagliflozin propanediol -
xigduo 5/1000 mg 56 comprimits recoberts
xigduo 5/850 mg 56 comprimits recoberts
xigduo xr 10 mg / 500 mg comprimidos de liberación prolongada recubiertos con película
astrazeneca camcar, s.a. - metformina clorhidrato - metformina clorhidrato ....500 mg / dapagliflozina (propanodiol)....10 mg
xigduo xr 10 mg/500 mg film coted tablet film-coated tablet
astrazeneca ab, sweden - metformin hydrochloride,dapagliflozin - film-coated tablet - 500,10 mg,
xigduo xr 5 mg/500 mg film coted tablet film-coated tablet
astrazeneca ab, sweden - metformin hydrochloride,dapagliflozin - film-coated tablet - 500,10 mg,
xigduo™ xr 10 mg/1000 mg tablet
modern pharmaceutical company united states of america - 30's [5 x 6's blister] - tablet - 10 mg/1000 mg - endocrine system-diabetes
xigduo™ xr 5 mg/1000 mg tablet
modern pharmaceutical company united states of america - 60's [2 x (5 x 6's blister)] - tablet - 5 mg/1000 mg - endocrine system-diabetes
xigduo™ xr 10 mg/500 mg
30's [5 x 6's blister] -